Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Mais filtros

Base de dados
Ano de publicação
Tipo de documento
Intervalo de ano de publicação
1.
Eur J Pharm Biopharm ; 202: 114416, 2024 Sep.
Artigo em Inglês | MEDLINE | ID: mdl-39013494

RESUMO

Owing to its exposed nature, the skin can be injured by various factors, including by Staphylococcus aureus, which inhabits its innate microbiota. Treatment of infected wounds presents an important challenge, making it imperative to develop new treatment options. Plant-derived formulations, such as those containing Melaleuca alternifolia essential oil (MaEO), are used for wound treatment because of their healing, anti-inflammatory, and antimicrobial properties. This study presents a cream containing 2% MaEO (2% CMa) and evaluates its effects in an S. aureus-infected wound murine model. The 2% CMa was subjected to quality control testing and pH and analysis of density, organoleptic characteristics, and microbiological effects. The quality control parameters all revealed the good stability of the 2% CMa. The formulation strongly reduced the S. aureus ATCC 6538 colony-forming unit (CFU) count in an ex vivo porcine skin model. In the murine model, daily topical application of 2% CMa reduced the severity and size of S. aureus-infected wounds and the bacterial load. These effects may be due to the presence of terpinen-4-ol, which exhibits anti-inflammatory activity. Based on these findings, the formulation exhibits good quality and safety. We suggest the topical application of this formulation, which exhibited an antimicrobial effect, as an interesting treatment strategy for wound healing.


Assuntos
Melaleuca , Óleos Voláteis , Infecções Estafilocócicas , Staphylococcus aureus , Cicatrização , Animais , Cicatrização/efeitos dos fármacos , Staphylococcus aureus/efeitos dos fármacos , Camundongos , Melaleuca/química , Óleos Voláteis/farmacologia , Óleos Voláteis/administração & dosagem , Suínos , Infecções Estafilocócicas/tratamento farmacológico , Infecções Estafilocócicas/microbiologia , Infecção dos Ferimentos/tratamento farmacológico , Infecção dos Ferimentos/microbiologia , Antibacterianos/farmacologia , Antibacterianos/administração & dosagem , Óleo de Melaleuca/farmacologia , Óleo de Melaleuca/administração & dosagem , Óleo de Melaleuca/química , Pele/efeitos dos fármacos , Pele/microbiologia , Produtos Biológicos/farmacologia , Produtos Biológicos/administração & dosagem , Produtos Biológicos/química , Feminino , Modelos Animais de Doenças , Masculino
2.
Biomed Pharmacother ; 173: 116389, 2024 Apr.
Artigo em Inglês | MEDLINE | ID: mdl-38461682

RESUMO

Staphylococcus aureus is one of the most common bacterial isolates found in wounds. Thus, innovative dressings, such as hydrogels, are interesting vehicles for incorporating bioactive compounds like those from Melaleuca alternifolia essential oil (MaEO). In this study, we evaluated the antimicrobial and anti-inflammatory potential of MaEO incorporated into an alginate and chitosan hydrogel for treating wounds infected by S. aureus. The hydrogel incorporated with MaEO 1% (HMa 1%) was homogeneous with a bright pale-yellow color and the characteristic smell of Melaleuca. The incorporation of MaEO 1% does not affect the stability of the hydrogel, which was stable up to 90 days of storage. The Scanning electron microscopy analysis revealed that hydrogels showed irregular surfaces and interconnected porous structures with accumulations of oil crystals distributed throughout the formulation. HMa 1% has a high moisture content (95.1%) and can absorb simulated wound fluid. Regarding the antimicrobial effects, HMa 1% reduced the growth of S. aureus ATCC 6538 in both in vitro conditions and in an ex vivo model of wounds using porcine skin. In addition, the dairy topical treatment of murine skin lesions with HMa 1% induced a significant reduction of the wound area, inflammation score, and bacterial load, as well as tissue re-epithelialization and modulation of inflammatory mediators. Therefore, hydrogel incorporated with MaEO 1% has excellent potential to be used in the pharmacotherapy of infected wounds.


Assuntos
Anti-Infecciosos , Melaleuca , Óleos Voláteis , Infecções Estafilocócicas , Óleo de Melaleuca , Suínos , Animais , Camundongos , Staphylococcus aureus , Óleos Voláteis/farmacologia , Óleos Voláteis/uso terapêutico , Óleos Voláteis/química , Melaleuca/química , Hidrogéis/farmacologia , Hidrogéis/uso terapêutico , Anti-Infecciosos/farmacologia , Infecções Estafilocócicas/tratamento farmacológico , Óleo de Melaleuca/farmacologia , Óleo de Melaleuca/uso terapêutico , Antibacterianos/farmacologia , Antibacterianos/uso terapêutico
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA